Patents by Inventor Philippe Soriano

Philippe Soriano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12331221
    Abstract: A thermo-fusible adhesive composition comprising at least one ethylene and butyl acrylate copolymer cohesion agent. The thermo-fusible adhesive composition may further comprise at least one adhesive hydrocarbon resin, preferably hydrogenated, and at least one ethylene and acrylate copolymer. The present disclosure also relates to the use of the corresponding thermo-fusible adhesive compositions in the production of manufactured articles.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: June 17, 2025
    Assignee: SK GLOBAL CHEMICAL CO., LTD.
    Inventors: Jean-Michel Bruneau, Martine Le Nobin, Jean-Philippe Soriano, Florence Quetel
  • Publication number: 20200071575
    Abstract: The present invention relates to the use of at least one ethylene and butyl acrylate copolymer, as defined below, as a cohesion agent, in a hot-melt adhesive composition. The invention also relates to a hot-melt adhesive composition comprising at least one adhesive hydrocarbon resin, preferably hydrogenated, and at least one ethylene and acrylate copolymer as defined below. The invention also relates to the use of the corresponding hot-melt adhesive composition for the production of a manufactured article.
    Type: Application
    Filed: December 22, 2017
    Publication date: March 5, 2020
    Inventors: Jean-Michel BRUNEAU, Martine LE NOBIN, Jean-Philippe SORIANO, Florence QUETEL
  • Publication number: 20160083699
    Abstract: The present invention provides an optimized FLP site-specific recombinase coding sequence and methods for its use. This genetically engineered FLP gene displays a marked increase in recombination efficiency compared to the native FLP gene and is therefore useful in a wide array of molecular applications.
    Type: Application
    Filed: December 4, 2015
    Publication date: March 24, 2016
    Inventors: Christopher Raymond, Philippe Soriano
  • Patent number: 9206397
    Abstract: The present invention provides an optimized FLP site-specific recombinase coding sequence and methods for its use. This genetically engineered FLP gene displays a marked increase in recombination efficiency compared to the native FLP gene and is therefore useful in a wide array of molecular applications.
    Type: Grant
    Filed: June 21, 2007
    Date of Patent: December 8, 2015
    Assignee: The Fred Hutchinson Cancer Research Center
    Inventors: Christopher Raymond, Philippe Soriano
  • Publication number: 20100050279
    Abstract: The present invention provides an optimized FLP site-specific recombinase coding sequence and methods for its use. This genetically engineered FLP gene displays a marked increase in recombination efficiency compared to the native FLP gene and is therefore useful in a wide array of molecular applications.
    Type: Application
    Filed: June 21, 2007
    Publication date: February 25, 2010
    Inventors: Christopher Raymond, Philippe Soriano
  • Patent number: 6461864
    Abstract: Transgenic non-human animals one having a general deletor construct and a second having a general reporter construct are described. The general deletor animals express a heterologous recombinase under the control of an ubiquitously expressed endogenous promoter. Specifically, the Cre recombinase is inserted into the ROSA26 locus of the mouse. The general reporter animals have a gene which is desired to remove flanked by sites recognized by the is heterologous recombinase. This flanked sequence is operatively associated with a marker gene such that when the gene sequence flanked by sites recognized by the heterologous recombinase is excised, the reporter gene is expressed. When the general deletor mouse is crossed with the general reporter mouse the heterologous recombinase is expressed in essentially all cells of the resultant descendants under the control of the ubiquitous promoter. Expression of the recombinase results in the excision of the desired gene in essentially all cells of the descendant animals.
    Type: Grant
    Filed: April 14, 1999
    Date of Patent: October 8, 2002
    Assignee: Fred Hutchinson Cancer Research Center
    Inventors: Philippe Soriano, Elizabeth J. Robertson